Skip to main content
CREO MEDICAL GROUP PLC logo

CREO MEDICAL GROUP PLC — Investor Relations & Filings

Ticker · CREO ISIN · GB00BZ1BLL44 LEI · 213800H188ZDCWWXFA21 IL Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2025-07-10 Regulatory Filings
Country GB United Kingdom
Listing IL CREO

About CREO MEDICAL GROUP PLC

https://www.creomedical.com/

Creo Medical Group PLC is a medical device company specializing in the development and commercialization of minimally invasive electrosurgical devices for therapeutic endoscopy. The company's core technology platform integrates advanced bipolar radiofrequency for precise tissue cutting with high-frequency microwave energy for controlled coagulation. Its principal products, such as the Speedboat device, are designed to enable clinicians to perform complex procedures like endoscopic submucosal dissection (SSD) to remove gastrointestinal lesions. By providing alternatives to traditional surgery, Creo Medical aims to improve patient outcomes, reduce recovery times, and lower healthcare costs. The company also provides extensive clinical education and training programs to support healthcare professionals in adopting its advanced energy technologies.

Recent filings

Filing Released Lang Actions
MicroBlate™ Flex begins lung tumour clinical study
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number (4460Q) and contains an announcement from Creo Medical Group plc regarding a clinical study milestone ('MicroBlate™ Flex begins landmark lung tumour post-market clinical study'). It includes company updates, CEO commentary, and contact information, typical of a press release distributed via the Regulatory News Service (RNS). Since it is an announcement of operational/clinical progress rather than a formal financial report (like 10-K, IR, ER) or a specific corporate action filing (like DIV, CAP, DIRS), the most appropriate classification is the general regulatory announcement category, RNS.
2025-07-10 English
PDMR Options Revision
Remuneration Information Classification · 1% confidence The document is identified by the RNS Number (3572Q) and explicitly states it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content announces a change in the exercise price of options granted to Persons Discharging Managerial Responsibilities (PDMRs) (Craig Gulliford, CEO, and Richard Rees, CFO). This type of announcement, concerning insider transactions or dealings by directors/executives, most closely aligns with the 'Director's Dealing' category (DIRS). Although it involves executive compensation changes, it is a specific transaction disclosure rather than a general remuneration report (DEF 14A). Since it is a formal regulatory announcement distributed via RNS regarding executive share dealings, DIRS is the most specific fit, although RNS is the distribution channel.
2025-07-09 English
Change of Nominated Adviser
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated '30 June 2025'. It announces a 'Change of Nominated Adviser' from Numis Securities Limited to Deutsche Bank AG, London Branch, effective immediately. The text explicitly mentions that this information is provided by 'RNS, the news service of the London Stock Exchange' and that RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider. This structure and source identification strongly indicate a general regulatory announcement disseminated via the London Stock Exchange's RNS system. Since the content is a specific corporate action announcement (change of adviser) that doesn't fit into the more specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), the most appropriate classification is the general regulatory announcement category, RNS.
2025-06-30 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Result of AGM' and mentions that 'all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed.' It also notes that the voting results will be made available shortly. This content directly relates to the outcome of the Annual General Meeting. Although it mentions the results will be posted later, the primary subject is the AGM outcome itself, which aligns best with the AGM Information (AGM-R) category, which covers presentations and materials shared during the AGM. Since this is the result announcement, it is closely related to the AGM process. If the document were only announcing *when* the results would be posted without stating the outcome, it might lean towards RPA/RNS, but here the result (all passed) is the core message. However, the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)' is specifically defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Since this document declares the results (all passed), DVA is the most precise fit.
2025-06-26 English
AGM Statement and Directorate Changes
AGM Information Classification · 1% confidence The document is an official RNS announcement from Creo Medical Group PLC titled 'AGM Statement and Directorate Changes'. It contains the Chairman's address to shareholders at the Annual General Meeting (AGM) and details regarding changes to the Board of Directors. Since it provides the content of the statement delivered at the AGM, it falls under the AGM Information category.
2025-06-26 English
U.S. FDA clearance for SpydrBlade™ Flex
Regulatory Filings Classification · 1% confidence The document starts with an 'RNS Number' and is dated June 11, 2025. The content announces a significant operational event: receiving U.S. FDA clearance for a medical device (SpydrBlade™ Flex). This type of announcement, which details a specific, material event or operational update rather than comprehensive financial results (like 10-K or IR) or a general shareholder vote result, fits best under the general regulatory announcement category. Since it is not a standard earnings release (ER), a formal report (AR, 10-K, IR), or a management/board change (MANG), it is classified as a general Regulatory Filing (RNS). The document structure strongly resembles a standard regulatory news service release.
2025-06-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.